Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 42 results for "habil khorakiwala"

'Drug recall is to speed up the regulatory compliance process'
Money Today

Wockhardt charts growth plan, to add two hospitals every year

Mumbai, May 14 -- Wockhardt Hospitals Pvt. Ltd, part of the Habil Khorakiwala-promoted Wockhardt Group, has chalked out an expansion plan, nearly six years after it sold off a major portion of its business to Fortis Healthcare Ltd. In 2009, the ... HT Syndication, 1 week ago

1 images for "habil khorakiwala"

Money Today, 2 weeks ago

Wockhardt stock surges on QIDP designation for WCK 4873 from U.S. FDA

News Top News Top Story India Infoline News Service | Mumbai | May 22, 2015 16:43 IST This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug ...
 India Infoline4 hours ago Wockhardt 's new antibiotic drug WCK 4873 gets QIDP status from US FDA  PharmaBiz6 hours ago Wockhardt gets special status in US on antibiotics  Hindu Business Line22 hours ago Wockhardt gets QIDP status for pneumonia drug from USFDA  Economic Times1 day ago
NDTV Profit

Wockhardt Gains on US Drug Regulator Nod

Wockhardt shares gained nearly 4 per cent to Rs 1459.50 on Friday, after the company received a QIDP or qualified infectious disease product status from the US Food and Drug Administration (FDA) for one of its products. Wockhardt shares at 11:28 ...
 NDTV Profit10 hours ago Wockhardt shares up 2% on FDA grants QIDP status to new drug  Business Today India10 hours ago
DNA India

Wockhardt recalls 12 drugs in US made at two India units

Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana and Waluj facilities prior to the import alert imposed by the US Food and Drug Administration (US FDA) recently.
 Financial Express1 day ago Wockhardt faces long haul on FDA travails, Business Today says  FierceMedicalDevices2 days ago Now, 93,393 bottles of blood pressure drug recalled by Wockhardt  DNA India1 week ago Troubled Wockhardt recalls blood pressure med in U.S.  FiercePharmaManufacturing1 week ago

Mukesh Ambani - The Richest Indian for Eighth Consecutive Year

Browse more on » Other , Awards Mukesh Ambani ranked first in Forbes list of 100 richest Indian tycoons. This is the eighth time in a row that the Chairman of Reliance Industries has topped the list. Tweet Mumbai, Maharashtra, April 29, 2015 / ...
 IndiaPRwire1 week ago

Billionaires poorer by over $4.6b

Indian billionaires have lost a whopping $4.6 billion in Wednesday’s market crash with pharma king Dilip Shanghvi, banker Uday Kotak and infra and commodities czar Gautam Adani bearing the maximum brunt in terms of loss of notional wealth. Among the over 80 ...
 The Financial Chronicle2 weeks ago

Live market updates: Rupee closes at 63.15, marks its sharpest gain since 9 Jan

5:00pm: The Indian rupee closes 0.55% stronger against the dollar at 63.15, marking its sharpest gain since 9 January. Read more 3:30pm: The S&P BSE Sensex closes 0.81%, or 219.39 points, higher at 27,396.38, while the Nifty added 0.87%, or 71.80 ...
 Livemint.com3 weeks ago

Live market updates: Sensex surges 302 points, Nifty tops 8300

India April 28(IM):The S&P BSE Sensex surges 1.11%, or 301.82 points, to 27,478.81, while the CNX Nifty rises 1.10%, or 90.20 points, to 8,304. 2:58pm: The S&P BSE Sensex surges 1.04%, or 283.69 points, to 27,460.68, while the CNX Nifty rises 0.95%, ...
 Indian Mirror3 weeks ago
Financial Express

Pharma companies eye US complex generics market

Indian pharmaceutical companies have reaped significant gains from sale of cheaper generic versions of blockbuster drugs in the US market. Now, the next frontier is the complex generics market to ride the next wave of growth. This high potential ...
 Financial Express1 month ago

End of Wockhardt's Chikalthana USFDA woes?

No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana facilities Wockhardt Pharma's Chikalthana facility in Maharashtra recently underwent a 10-day-long inspection by the ...
 Financial Express1 month ago Wockhardt's Chikalthana plant to regain the lost ground soon  Financial Express2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less